Parnell Acquires Noble Pharma LLC
April 11, 2026
Parnell announced it has acquired Noble Pharma LLC, a U.S.-based pharmaceutical manufacturer, under a Securities Purchase Agreement dated November 26, 2025. The deal adds an FDA- and DEA-accredited manufacturing facility in Menomonie, Wisconsin, to strengthen Parnell’s U.S. manufacturing capabilities and supply continuity.
- Buyers
- Parnell
- Targets
- Noble Pharma LLC
- Industry
- Healthcare Services
- Location
- Wisconsin, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.